Characterisation of a novel group B oncolytic adenovirus, ColoAd1

Characterisation of a novel group B oncolytic adenovirus, ColoAd1

Zobrazit další vydání (1)

<p>Developing high potent oncolytic virus with multimodal antitumour capabilities is crucial for realizing the full potential of oncolytic virotherapy in cancer treatment. ColoAd1 is a novel replicating chimeric group B adenovirus recently bioselected from a large library of recombinant virus...

Podrobná bibliografie
Hlavní autor:	Di, Y
Další autoři:	Seymour, L
Médium:	Diplomová práce
Jazyk:	English
Vydáno:	2011
Témata:	Oncology

Podobné jednotky

Characterisation of a novel group B oncolytic adenovirus, ColoAd1
Autor: Di, Y, a další
Vydáno: (2011)

Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
Autor: Koelen, J
Vydáno: (2015)

Investigating the oncolytic properties of a group B adenovirus on cancer cells and its effects on the local immune response
Autor: Calderon, H
Vydáno: (2017)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
Autor: Dyer, A
Vydáno: (2021)

Bioprocessing of oncolytic group B adenovirus for scalable production
Autor: Cooper, L
Vydáno: (2014)

Exploring the effects of nutrient deprivation and waste accumulation on T cells and oncolytic adenoviruses; in order to create immune activators for tumour therapy
Autor: Frost, SC
Vydáno: (2020)

Oncolytic Replication of E1b-Deleted Adenoviruses
Autor: Pei-Hsin Cheng, a další
Vydáno: (2015-11-01)

Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus
Autor: Illingworth, S, a další
Vydáno: (2017)

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
Autor: Sam Illingworth, a další
Vydáno: (2017-06-01)

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
Autor: Ryosuke Ono, a další
Vydáno: (2021-03-01)

A Renaissance for Oncolytic Adenoviruses?
Autor: Paola Blanchette, a další
Vydáno: (2023-01-01)

Oncolytic Adenoviruses in Cancer Treatment
Autor: Ramon Alemany
Vydáno: (2014-02-01)

Oncolytic Adenoviruses in Gastrointestinal Cancers
Autor: Raquel T. Yokoda, a další
Vydáno: (2018-03-01)

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
Autor: Virginia Laspidea, a další
Vydáno: (2022-04-01)

Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus
Autor: Warren Floyd, a další
Vydáno: (2023-07-01)

Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer
Autor: Xiao-yu Chen, a další
Vydáno: (2024-11-01)

Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009
Autor: Samuel T. Pellom, a další
Vydáno: (2021-04-01)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
Autor: Tiffany Y. Ho, a další
Vydáno: (2021-09-01)

Investigation of strategies to enhance the delivery of oncolytic vaccinia virus
Autor: Hill, C
Vydáno: (2020)

Adenovirus as a Vector and Oncolytic Virus
Autor: Wataru Matsunaga, a další
Vydáno: (2023-06-01)

Oncolytic adenovirus for treatment of malignant ascites
Autor: Akseli Hemminki, a další
Vydáno: (2022-09-01)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
Autor: William S. M. Wold, a další
Vydáno: (2010-08-01)

Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade
Autor: Sharmila Nair, a další
Vydáno: (2021-01-01)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Autor: Hanni Uusi-Kerttula, a další
Vydáno: (2015-11-01)

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Autor: Dyer, A, a další
Vydáno: (2016)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
Autor: Lei, J, a další
Vydáno: (2018)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells
Autor: Janet Lei, a další
Vydáno: (2018-06-01)

Pharmacoproteomic characterisation of human colon and rectal cancer
Autor: Frejno, M
Vydáno: (2016)

Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
Autor: Marc Garcia‐Moure, a další
Vydáno: (2024-04-01)

HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Autor: Deng Youwen, a další
Vydáno: (2010-05-01)

Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Autor: Arthur Dyer, a další
Vydáno: (2017-03-01)

Species D Adenoviruses as Oncolytic Viral Vectors
Autor: Brianna L. Bullard, a další
Vydáno: (2020-12-01)

The gamble between oncolytic virus therapy and IFN
Autor: Qingbo Li, a další
Vydáno: (2022-08-01)

Characterisation of Topoisomerase 1-cleavage complex repair
Autor: Lascaux, P
Vydáno: (2024)

Novel Chitosan-Coated Liposomes Coloaded with Exemestane and Genistein for an Effective Breast Cancer Therapy
Autor: Shwetakshi Sharma, a další
Vydáno: (2024-02-01)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
Autor: Thoma, CMM
Vydáno: (2011)

Identification and characterisation of determinants of genome stability in response to a double-strand break
Autor: Kasparek, TR
Vydáno: (2013)

Relevance of specific oncolytic adenovirus in regulating PD-L1 expression in prostate cancer
Autor: Di Zhang, a další
Vydáno: (2023-05-01)

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
Autor: Victor A. Naumenko, a další
Vydáno: (2022-07-01)

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Autor: Daoyuan Xie, a další
Vydáno: (2023-11-01)